Medical Treatment & Drug Development
Post-Doctoral Fellowships
France
Viral engineering for the treatment of neurogenic detrusor overactivity due to spinal cord injury: proof of concept study
This researcher is also supported by the Garches Foundation.
Curing bladder hyperactivity in spinal cord injured patients using gene therapy?
To add or modify information on this page, please contact us at the following address: community.research@axa.com

Pierre
CLEMENT
Institution
Fondation Garches
Country
France
Nationality
French
Related articles
Chronic & Non-communicable Diseases
Medical Treatment & Drug Development
AXA Project
France
Pain Pediatric & Elderly AXA Research Lab (PEARL)
Cutaneous neuropathic pain is a highly debilitating chronic condition, characterized by persistent sensations of burning, tingling, or hypersensitivity. It disproportionately... Read more
Celine
GRECO
Hôpital Necker-Enfants Malades
Medical Treatment & Drug Development
Mécénat des Mutuelle
France
Accelerating drug innovation with the Euridis school and its DDD Challenge
The project addresses a dual challenge: on one hand, the increasing complexity of drug development, which requires a thorough understanding... Read more

Laurence
SABATIER
Institut du médicament de Strasbourg
Medical Treatment & Drug Development
Mécénat des Mutuelle
France
New Molecule to Combat Antibiotic-Resistant Childhood Sepsis
The global spread of antibiotic resistance requires the identification of new bacterial drug targets, the design and synthesis of innovative... Read more

Nalini
RAMA RAO